{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:38:13Z","timestamp":1768822693932,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T00:00:00Z","timestamp":1089849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00296-004-0484-7","type":"journal-article","created":{"date-parts":[[2004,7,14]],"date-time":"2004-07-14T09:33:01Z","timestamp":1089797581000},"page":"599-603","source":"Crossref","is-referenced-by-count":27,"title":["Vascular endothelial and basic fibroblast growth factor serum levels in patients with Beh\u00e7et\u2019s disease"],"prefix":"10.1007","volume":"25","author":[{"given":"Fuat","family":"Erdem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"G\u00fcndo\u011fdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhami","family":"Kiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Refik Ali","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Kiziltun\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,15]]},"reference":[{"key":"484_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00002281-199901000-00009","volume":"11","author":"Yaz","year":"1999","unstructured":"Yaz\u0131c\u0131 H, Yurdakul S, Hamuryudan V (1999) Beh\u00e7et\u2019s syndrome. Curr Opin Rheumatol 11:53\u201357","journal-title":"Curr Opin Rheumatol"},{"key":"484_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00296-001-0148-9","volume":"21","author":"Saglam","year":"2002","unstructured":"Saglam K, Yilmaz MI, Saglam A et al (2002) Levels of circulating intercellular adhesion molecule-1 in patients with Beh\u00e7et\u2019s disease. Rheumatol Int 21:146\u2013148","journal-title":"Rheumatol Int"},{"key":"484_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/pmj.76.900.629","volume":"76","author":"Kontogiannis","year":"2000","unstructured":"Kontogiannis V, Powell RJ (2000) Beh\u00e7et\u2019s disease. Postgrad Med J 76:629\u2013637","journal-title":"Postgrad Med J"},{"key":"484_CR4","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G (1999). Behcet\u2019s disease. N Engl J Med 341:1284\u20131291","journal-title":"N Engl J Med"},{"key":"484_CR5","unstructured":"Gul A (2001) Beh\u00e7et\u2019s disease: an update on the pathogenesis. Clin Exp Rheumatol 19 [Suppl]:S6\u2013S12"},{"key":"484_CR6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1365-2249.2003.02101.x","volume":"132","author":"Drouart","year":"2003","unstructured":"Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132:158\u2013162","journal-title":"Clin Exp Immunol"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0961203302lu131oa","volume":"11","author":"Navarro","year":"2002","unstructured":"Navarro C, Candia-Zuniga, Silveira LH, Ruiz V, Gaxiola M, Avila MC, Amigo MC (2002) Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 11:21\u201324","journal-title":"Lupus"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","volume":"96","author":"Aguayo","year":"2000","unstructured":"Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96:2240\u20132245","journal-title":"Blood"},{"key":"484_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1191\/0961203302lu199oa","volume":"11","author":"Robak","year":"2002","unstructured":"Robak E, Wozniacka A, Sysa-Jedrzejowska A, Stepien H, Robak T (2002) Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Lupus 11:348\u2013355","journal-title":"Lupus"},{"key":"484_CR10","first-page":"445","volume":"12","author":"Robak","year":"2001","unstructured":"Robak E, Wozniacka A, Sysa-Jedrzejowska A et al (2001) Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw 12:445\u2013452","journal-title":"Eur Cytokine Netw"},{"key":"484_CR11","doi-asserted-by":"crossref","unstructured":"Harada M, Mitsuyama K, Yoshida H et al (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27 377\u2013380","DOI":"10.1080\/03009749850154429"},{"key":"484_CR12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1365-2133.1998.02563.x","volume":"139","author":"Kikuchi","year":"1998","unstructured":"Kikuchi K, Kubo M, Kadano T, Yazawa N, Ihn H, Tamaki K (1998) Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 139:1049\u20131051","journal-title":"Br J Dermatol"},{"key":"484_CR13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31:205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"484_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1163\/156856903321579280","volume":"15","author":"Kiziltun","year":"2003","unstructured":"Kiziltun\u00e7 A, Yildirim AK, Kele\u015f MS, Ko\u00e7er I, Aksoy H, Ba\u015fo\u011flu M et al (2003) Serum soluble intercellular adhesion molecule-1, interleukin-8 and interleukin-6 levels in patients with Behcet\u2019s disease. The Pain Clinic 15:159\u2013165","journal-title":"The Pain Clinic"},{"key":"484_CR15","first-page":"1078","volume":"335","author":"International","year":"1990","unstructured":"International Study Group for Beh\u00e7et\u2019s disease (1990) Criteria for diagnosis of Beh\u00e7et\u2019s Disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"484_CR16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000051544","volume":"201","author":"Evereklio","year":"2000","unstructured":"Evereklio\u011flu C, Y\u00fcrekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Beh\u00e7et\u2019s disease. Dermatology 201:312\u2013315","journal-title":"Dermatology"},{"key":"484_CR17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1021588227705","volume":"5","author":"Larsson","year":"2002","unstructured":"Larsson A, Sk\u00f6ldenberg E, Ericson H (2002) Serum and plasma levels of FGF-2 and VEGF in healthy blood donors. Angiogenesis 5:107\u2013110","journal-title":"Angiogenesis"},{"key":"484_CR18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)01137-2","volume":"37","author":"Chambers","year":"2001","unstructured":"Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Beh\u00e7et\u2019s syndrome. JACC 37:517\u2013520","journal-title":"JACC"},{"key":"484_CR19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/ard.60.12.1081","volume":"60","author":"Leiba","year":"2001","unstructured":"Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behcet\u2019s disease and thrombophilia. Ann Rheum Dis 60:1081\u20131085","journal-title":"Ann Rheum Dis"},{"key":"484_CR20","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1053\/ejvs.2000.1091","volume":"19","author":"Demirer","year":"2000","unstructured":"Demirer S, Sengul N, Yardel MA, Tuzuner A et al (2000) Haemostasis in patients with Beh\u00e7et\u2019s disease. Eur J Vasc Endovasc Surg 19:570\u2013574","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"484_CR21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1614108","volume":"84","author":"Williams","year":"2000","unstructured":"Williams FM, Parmar K, Hughes GR, Hunt BJ (2000) Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 84:742\u2013746","journal-title":"Thromb Haemost"},{"key":"484_CR22","first-page":"321","volume":"19","author":"Lee","year":"2001","unstructured":"Lee S, Joo YS, Kim Wu et al (2001) Vascular endothelial growth factor levels in serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321\u2013324","journal-title":"Clin Exp Rheumatol"},{"key":"484_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s004030000128","volume":"292","author":"Zouboulis","year":"2000","unstructured":"Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE (2000) Adamantiades-Behcet\u2019s disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279\u201384","journal-title":"Arch Dermatol Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0484-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-004-0484-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-004-0484-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T18:49:52Z","timestamp":1585853392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-004-0484-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s00296-004-0484-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}